Jerry Flanagan was formerly Consumer Watchdog’s Litigation Director. Flanagan lead Consumer Watchdog’s litigation efforts in the areas of health insurance coverage and access to treatments, internet privacy, the California Public Records Act, and First Amendment issues.
Flanagan spearheaded efforts to address discrimination against those with HIV and other serious illnesses in the era of the Affordable Care Act (aka “Obamacare”).
Flanagan was counsel of record in a case before the United States Supreme Court where he and other Consumer Watchdog counsel represented plaintiffs living with HIV in a suit against CVS for discrimination, including CVS’s failure to provide medically appropriate dispensing of HIV medications and access to necessary counseling. After Consumer Watchdog’s unanimous win in the Ninth Circuit Court of Appeals, CVS petitioned to the high court for review. Review was granted and the case was briefed, but CVS unexpectedly dropped the case, leaving the earlier victory intact. Doe v. CVS Pharmacy, Inc. (9th Cir. 2020) 982 F.3d 1204, cert. granted in part, (2021) 141 S. Ct. 2882, and cert. dismissed sub nom. CVS Pharmacy, Inc. v. Doe, One (2021) 142 S. Ct. 480.
Flanagan exposed the illegal practice of health insurers retroactively canceling coverage and authored a law journal article underscoring the need for reform in health insurance rescission law, Healthy State of Mind: The Role of Intent in Health Plan Rescissions, 43 Loy. L.A. L. Rev. 291 (2009). An “intentional misrepresentation” standard for coverage rescissions, advocated by the article, was adopted in the ACA.
Prior to joining Consumer Watchdog, Flanagan drafted and won passage of one of the nation’s strongest HMO accountability measure, which was signed into law in New Jersey in 2001.
Class Action Lawsuit Barring “Bait and Switch†Health Plan Deductibles Advances
According To Blue Cross, “Any Term or Benefit” of Health Coverage Could Change Each Month
Santa Monica, CA.Blue Cross Suspends Mandatory HIV/AIDS Drug Mail Order Program
Santa Monica, CA -- In response to consumer complaints and a class action lawsuit on behalf of HIV/AIDS patients in California, Anthem Blue Cross has agreed to suspend a program that would have barred patients from purchasing certain specialty medications at local pharmacies. Under the program, patients would have been required to obtain their medications by mail order, threatening their health and privacy according to the lawsuit
Blue Cross Sued for Discriminating Against HIV/AIDS Patients
San Diego, CA -- In a move that threatens the health and privacy of patients, Blue Cross of California has illegally targeted HIV/AIDS patients, and other seriously ill consumers, with a new program that will bar them from local pharmacies, according to a new statewide class action lawsuit.
Did Your Blue Shield Health Insurance Rates Increase?
When will health insurers get the message? They can't raise our rates and cut our benefits and expect to get away with it! Drop us an email and help teach the insurance companies a lesson.
Update: Blue Cross Notices of Right to Change Coverage
This week more than 100,000 California Blue Cross consumers will receive notice of their right to change coverage under a settlement in the Feller v. Blue Cross class action lawsuit.